Automate CGM Prior Auth for Faster Patient Access and Revenue Capture
Klivira automates the complex and time-consuming process of CGM prior auth, ensuring patients receive timely access to continuous glucose monitoring devices while optimizing your revenue cycle.
Manual CGM prior authorization workflows are a significant bottleneck, leading to administrative overhead, delayed patient care, and potential revenue loss. The specific documentation requirements, such as diabetes type and insulin dependence, often require extensive chart review and multiple payer interactions. Klivira addresses these challenges by transforming the CGM prior auth process into an efficient, automated workflow.
Streamlining CGM Prior Authorization Workflows
The unique requirements for continuous glucose monitor (CGM) prior authorizations demand a precise and automated approach. Klivira's platform is engineered to navigate these complexities, from initial device approval to ongoing supply re-authorization. We ensure that critical documentation, including proof of insulin dependence and diabetes type, is accurately compiled and submitted, reducing manual effort and improving approval rates.
Key Workflows Automated for CGM Prior Auth
- Initial CGM authorization for new prescriptions
- Supply re-authorization for ongoing continuous glucose monitor use
- Verification of medical necessity criteria (e.g., insulin use, A1C levels)
- Automated aggregation of required clinical documentation from EMRs
- Submission of X12 278 and ePA transactions to payer portals
Optimizing Documentation for CGM Approvals
Successful CGM prior authorizations hinge on comprehensive and accurate documentation. Klivira's intelligent engine identifies and extracts relevant clinical data from your EMR, including physician notes, lab results, and medication lists, to substantiate medical necessity. This automation minimizes the risk of denials due to incomplete or incorrect submissions, accelerating the path to approval for essential diabetes management tools.
Seamless Integration with Your Existing Systems
Klivira integrates directly with your EMR via SMART on FHIR, enabling bidirectional data exchange for CGM prior auth requests. Our platform also connects with a vast network of payer portals, facilitating the automated submission and tracking of X12 278 transactions and Da Vinci PAS requests. This interoperability ensures that your prior authorization coordinators can manage all CGM approvals from a single, unified interface.
Impact on Revenue Cycle and Patient Access
By automating CGM prior authorizations, Klivira significantly reduces administrative burden, allowing your staff to focus on higher-value tasks. Faster approval times lead to improved patient access to continuous glucose monitoring devices, enhancing health outcomes and patient satisfaction. Furthermore, a reduction in prior authorization denials directly contributes to a healthier revenue cycle by minimizing rework and preventing lost revenue.
Frequently asked questions
What specific documentation does Klivira automate for CGM prior auth?
Klivira automates the aggregation of documentation proving medical necessity, including diabetes type (e.g., Type 1 or Type 2), evidence of insulin dependence, A1C levels, frequency of self-monitoring blood glucose, and relevant physician notes from the patient's EMR.
How does Klivira handle re-authorization for CGM supplies?
Klivira proactively tracks existing CGM authorizations and initiates the re-authorization process for supplies before expiration. This includes identifying updated clinical documentation, submitting renewal requests to payers, and ensuring continuous coverage for patients.
Does Klivira integrate with major EMRs for CGM prior auth data?
Yes, Klivira offers robust integration capabilities with leading EMR systems through industry-standard protocols like SMART on FHIR. This allows for seamless extraction of clinical data and demographic information required for CGM prior authorization submissions.
What payers does Klivira support for CGM prior authorizations?
Klivira supports a broad spectrum of commercial and government payers for CGM prior authorizations, leveraging direct portal integrations and standardized ePA transactions (e.g., X12 278, NCPDP SCRIPT). Our network is continuously expanded to cover a wide range of payer requirements.
How does automation improve turnaround times for CGM approvals?
Automation through Klivira streamlines data collection, reduces manual data entry errors, and accelerates submission to payers. This efficiency significantly shortens the overall prior authorization lifecycle for CGMs, leading to faster approvals and quicker patient access to devices.
Related coverage
Ready to ship this workflow?
See how Klivira automates prior authorizations for your team.
Request a demo